<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PeerJ</journal-id><journal-id journal-id-type="iso-abbrev">PeerJ</journal-id><journal-id journal-id-type="pmc">PeerJ</journal-id><journal-id journal-id-type="publisher-id">PeerJ</journal-id><journal-title-group><journal-title>PeerJ</journal-title></journal-title-group><issn pub-type="epub">2167-8359</issn><publisher><publisher-name>PeerJ Inc.</publisher-name><publisher-loc>San Diego, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">8855</article-id><article-id pub-id-type="doi">10.7717/peerj.8855</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bioinformatics</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Virology</subject></subj-group></article-categories><title-group><article-title>Prediction of antiviral drugs against African swine fever viruses based on protein&#x02013;protein interaction analysis</article-title></title-group><contrib-group><contrib id="author-1" contrib-type="author" equal-contrib="yes"><name><surname>Zhu</surname><given-names>Zhaozhong</given-names></name><xref ref-type="aff" rid="aff-1">1</xref></contrib><contrib id="author-2" contrib-type="author" equal-contrib="yes"><name><surname>Fan</surname><given-names>Yunshi</given-names></name><xref ref-type="aff" rid="aff-1">1</xref></contrib><contrib id="author-3" contrib-type="author"><name><surname>Liu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff-2">2</xref></contrib><contrib id="author-4" contrib-type="author"><name><surname>Jiang</surname><given-names>Taijiao</given-names></name><xref ref-type="aff" rid="aff-3">3</xref></contrib><contrib id="author-5" contrib-type="author" corresp="yes"><name><surname>Cao</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff-2">2</xref><email>cao@scu.edu.cn</email></contrib><contrib id="author-6" contrib-type="author" corresp="yes"><name><surname>Peng</surname><given-names>Yousong</given-names></name><xref ref-type="aff" rid="aff-1">1</xref><email>pys2013@hnu.edu.cn</email></contrib><aff id="aff-1">
<label>1</label><institution>College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Bioinformatics Center, Hunan University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff><aff id="aff-2">
<label>2</label><institution>Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country></aff><aff id="aff-3">
<label>3</label><institution>Center for Systems Medicine, Institute of Basic Medical Sciences, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences &#x00026; Peking Union Medical College</institution>, <addr-line>Suzhou</addr-line>, <country>China</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>de Azevedo</surname><given-names>Walter</given-names><suffix>Jr</suffix></name></contrib></contrib-group><pub-date pub-type="epub" date-type="pub" iso-8601-date="2020-04-01"><day>1</day><month>4</month><year iso-8601-date="2020">2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>8</volume><elocation-id>e8855</elocation-id><history><date date-type="received" iso-8601-date="2019-11-19"><day>19</day><month>11</month><year iso-8601-date="2019">2019</year></date><date date-type="accepted" iso-8601-date="2020-03-05"><day>5</day><month>3</month><year iso-8601-date="2020">2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Zhu et al.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Zhu et al.</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license></permissions><self-uri xlink:href="https://peerj.com/articles/8855"/><abstract><p>The African swine fever virus (ASFV) has severely influenced the swine industry of the world. Unfortunately, there is currently no effective antiviral drug or vaccine against the virus. Identification of new anti-ASFV drugs is urgently needed. Here, an up-to-date set of protein&#x02013;protein interactions between ASFV and swine were curated by integration of protein&#x02013;protein interactions from multiple sources. Thirty-eight swine proteins were observed to interact with ASFVs and were defined as ASFV-interacting swine proteins. The ASFV-interacting swine proteins were found to play a central role in the swine protein&#x02013;protein interaction network, with significant larger degree, betweenness and smaller shortest path length than other swine proteins. Some of ASFV-interacting swine proteins also interacted with several other viruses and could be taken as potential targets of drugs for broad-spectrum effect, such as HSP90AB1. Finally, the antiviral drugs which targeted ASFV-interacting swine proteins and ASFV proteins were predicted. Several drugs with either broad-spectrum effect or high specificity on ASFV-interacting swine proteins were identified, such as Polaprezinc and Geldanamycin. Structural modeling and molecular dynamics simulation showed that Geldanamycin could bind with swine HSP90AB1 stably. This work could not only deepen our understanding towards the ASFV-swine interactions, but also help for the development of effective antiviral drugs against the ASFVs.</p></abstract><kwd-group kwd-group-type="author"><kwd>Drug</kwd><kwd>ASFV</kwd><kwd>Prediction</kwd><kwd>PPI</kwd><kwd>Network</kwd><kwd>Interaction</kwd></kwd-group><funding-group><award-group id="fund-1"><funding-source>National Key Plan for Scientific Research and Development of China</funding-source><award-id>2016YFD0500300</award-id></award-group><award-group id="fund-2"><funding-source>Hunan Provincial Natural Science Foundation of China</funding-source><award-id>2018JJ3039</award-id></award-group><award-group id="fund-3"><funding-source>National Natural Science Foundation of China</funding-source><award-id>31500126 and 31671371</award-id></award-group><award-group id="fund-4"><funding-source>Chinese Academy of Medical Sciences</funding-source><award-id>2016-I2M-1-005</award-id></award-group><award-group id="fund-5"><funding-source>African Swine Fever</funding-source><award-id>2018NZ0151</award-id></award-group><funding-statement>This work was supported by the National Key Plan for Scientific Research and Development of China (2016YFD0500300), the Hunan Provincial Natural Science Foundation of China (2018JJ3039), the National Natural Science Foundation of China (31500126 and 31671371), the Chinese Academy of Medical Sciences (2016-I2M-1-005), and the funding for prevention and control technology of African swine fever (2018NZ0151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>African swine fever virus (ASFV), the causative agent of African swine fever (ASF), is an enveloped and double-stranded DNA virus with genome size ranging from 170 kbp to 194 kbp (<xref rid="ref-2" ref-type="bibr">Alonso et al., 2018</xref>). ASFV mainly infect suids and soft ticks (<xref rid="ref-55" ref-type="bibr">S&#x000e1;nchez-Cord&#x000f3;n et al., 2018</xref>). In swine populations, the virus can cause 100% mortality and severely influence the swine industry (<xref rid="ref-47" ref-type="bibr">Revilla, Perez-Nunez &#x00026; Richt, 2018</xref>). The ASFV has caused ASF outbreaks in more than 50 countries in Africa, Europe, Asia and South America until now (<xref rid="ref-13" ref-type="bibr">Costard et al., 2013</xref>; <xref rid="ref-39" ref-type="bibr">Malogolovkin et al., 2012</xref>). The latest reports showed that the virus has caused outbreaks in all provinces of mainland China (<xref rid="ref-64" ref-type="bibr">Zhou et al., 2018</xref>). How to effectively control the virus is still a great challenge for the globe (<xref rid="ref-59" ref-type="bibr">Wang et al., 2018</xref>).</p><p>Vaccine and antiviral drugs are believed to be the best tool for prevention and control of viral infection and spread (<xref rid="ref-41" ref-type="bibr">Monto, 2006</xref>). Unfortunately, all the attempts to develop effective vaccines against ASFVs had failed (<xref rid="ref-54" ref-type="bibr">S&#x000e1;nchez, P&#x000e9;rez-N&#x000fa;&#x000f1;ez &#x00026; Revilla, 2019</xref>). In the absence of vaccines against ASFVs, the antiviral drugs could not only improve host survival, but also help control the epidemic area (<xref rid="ref-63" ref-type="bibr">Zakaryan &#x00026; Revilla, 2016</xref>). Therefore, it is in great need to develop effective antiviral drugs against ASFVs. Several studies have identified multiple compounds which could inhibit ASFV infections. They could be classified into two groups (<xref rid="ref-6" ref-type="bibr">Arabyan et al., 2019</xref>). The first group of antiviral drugs has identified targets and known mechanisms, and includes five kinds of drugs: (i) nucleoside analogs, such as iododeoxyuridine (<xref rid="ref-26" ref-type="bibr">Gil-Fern&#x000e1;ndez et al., 1979</xref>), (S)-HPMPA (<xref rid="ref-25" ref-type="bibr">Gil-Fern&#x000e1;ndez et al., 1987</xref>) and Rigid amphipathic fusion inhibitors (<xref rid="ref-29" ref-type="bibr">Hakobyan et al., 2018</xref>); (ii) interferons (IFNs) and small peptides, such as IFN-alpha (<xref rid="ref-44" ref-type="bibr">Paez, Garcia &#x00026; Fernandez, 1990</xref>), IFN-gamma (<xref rid="ref-17" ref-type="bibr">Esparza, Gonz&#x000e1;lez &#x00026; Vi&#x000f1;uela, 1988</xref>) and small peptide inhibitors which could disrupt the interaction between cytoplasmic dynein and viral p54 protein (<xref rid="ref-33" ref-type="bibr">Hern&#x000e1;ez et al., 2010</xref>); (iii) plant-derived compounds, such as genistein (<xref rid="ref-5" ref-type="bibr">Arabyan et al., 2018</xref>) and genkwanin (<xref rid="ref-28" ref-type="bibr">Hakobyan et al., 2019</xref>). The former interferes with viral type II topoisomerase and the latter disrupts the virus movement along microtubules; (iv) antibiotics, such as Rifampicin (<xref rid="ref-15" ref-type="bibr">Dardiri, Bachrach &#x00026; Heller, 1971</xref>) and fluoroquinolone (<xref rid="ref-19" ref-type="bibr">Freitas et al., 2016</xref>; <xref rid="ref-42" ref-type="bibr">Mottola et al., 2013</xref>). They inhibit viral DNA-dependent RNA polymerase and type II topoisomerases, respectively; (v) small interfering RNA and CRISPR/Cas9. For example, some siRNAs (<xref rid="ref-36" ref-type="bibr">Keita, Heath &#x00026; Albina, 2010</xref>) which targeted viral genes such as A151R and B646L could significantly reduce the virus titer and RNA transcripts. The other group of antiviral drugs have unknown targets and unknown mechanism, such as Apigenin (<xref rid="ref-27" ref-type="bibr">Hakobyan et al., 2016</xref>), resveratrol (<xref rid="ref-23" ref-type="bibr">Galindo et al., 2011</xref>) and oxyresveratrol (<xref rid="ref-23" ref-type="bibr">Galindo et al., 2011</xref>). However, all the antiviral drugs mentioned above have not been taken forward for commercial production. More candidate drugs are needed for further development.</p><p>Although most antiviral drugs target the viral proteins, in recent years several studies have attempted to develop antiviral drugs which targeted the host proteins (<xref rid="ref-38" ref-type="bibr">Mak et al., 2019</xref>; <xref rid="ref-61" ref-type="bibr">Yang et al., 2019</xref>). Compared to the drugs which target viral proteins, the drugs targeting host proteins have more targets in the host cell since the number of host proteins is much larger than that of viral proteins. Besides, they may be more mutant-insensitive since the host proteins evolve much slower than viral proteins (<xref rid="ref-37" ref-type="bibr">Luo, Vasudevan &#x00026; Lescar, 2015</xref>; <xref rid="ref-50" ref-type="bibr">Rozenblatt-Rosen et al., 2012</xref>). With the rapid development of high-throughput assays, a large amount of protein&#x02013;protein interactions between virus and host has been accumulated. Analysis of these protein&#x02013;protein interactions in the perspective of network can help identify host proteins of importance for viral infection, which could be taken as potential targets for antiviral research (<xref rid="ref-58" ref-type="bibr">Uetz et al., 2006</xref>). For example, <xref rid="ref-30" ref-type="bibr">Han et al. (2017)</xref> predicted several antiviral drugs against human enterovirus 71 by systematic identification and analysis of protein&#x02013;protein interactions between the virus and the host, suggesting the important role of protein&#x02013;protein interaction analysis on developing antiviral drugs targeting host proteins.</p><p>Several studies have investigated the protein&#x02013;protein interactions between ASFV and swine. Some important interactions were listed as follows: the viral DP71L protein interacts specifically with and activates protein phosphatase 1 (PP1) (<xref rid="ref-48" ref-type="bibr">Rivera et al., 2007</xref>); the viral A224L interacts with the proteolytic fragment of caspase-3 and inhibits the activity of this protease during ASFV infection (<xref rid="ref-43" ref-type="bibr">Nogal et al., 2001</xref>); the viral p54 binds to the light chain of cytoplasmic dynein (LC8) to hijack the microtubule motor complex during ASFV infection (<xref rid="ref-3" ref-type="bibr">Alonso et al., 2001</xref>); the viral A238L binds to the catalytic subunit of calcineurin and inhibits NFAT-regulated gene transcription in vivo (<xref rid="ref-40" ref-type="bibr">Miskin et al., 1998</xref>); the viral p30 may down-regulate the mRNA translation of host cells by interacting with hnRNP-K (<xref rid="ref-32" ref-type="bibr">Hernaez, Escribano &#x00026; Alonso, 2008</xref>); the viral Ep152R interacts with BAG6 to block the immune response during viral infection (<xref rid="ref-9" ref-type="bibr">Borca et al., 2016</xref>); the viral A179L protein was able to interact with the main core Bcl-2 proapoptotic proteins Bax and Bak, and may play an important role during productive ASFV infection (<xref rid="ref-10" ref-type="bibr">Brun et al., 1996</xref>; <xref rid="ref-21" ref-type="bibr">Galindo et al., 2008</xref>). This study firstly curated a set of protein&#x02013;protein interactions between ASFV and swine proteins by integration of protein&#x02013;protein interactions from public databases and literatures; then, the swine proteins related to ASFV infection were identified; their roles in swine protein&#x02013;protein interaction network and in interacting with other viruses, and their functions were further investigated; finally, the candidate antiviral drugs targeting these swine proteins and ASFV proteins were predicted. This work could not only deepen our understanding towards the ASFV-swine interactions, but also help for the development of effective antiviral drugs against the ASFVs.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Protein&#x02013;protein interactions between ASFV and swine proteins</title><p>The protein&#x02013;protein interactions between ASFV and swine proteins were compiled from three sources (<xref ref-type="supplementary-material" rid="supp-3">Table S1</xref>). First of all, 24 protein&#x02013;protein interactions with median confidence (scores greater than 0.4) between ASFV and swine, were obtained from the database of Viruses.STRING (<xref rid="ref-12" ref-type="bibr">Cook et al., 2018</xref>) on 8 January 2019.</p><p>Secondly, 20 protein&#x02013;protein interactions between ASFV and swine were obtained from the literature. This was achieved by firstly searching the PubMed database by the key word &#x0201c;ASFV&#x0201d; in the title or abstract on 29 December 2018, which resulted in 630 abstracts. Then, each abstract was manually screened based on whether it contained protein&#x02013;protein interactions between ASFV and swine, and 117 abstracts were retained. Finally, the full texts of the manuscripts corresponding to these abstracts were read carefully and 20 extra protein&#x02013;protein interactions between ASFV and swine were compiled from these articles.</p><p>Thirdly, three protein&#x02013;protein interactions between ASFV and swine proteins were inferred based on sequence homology. This was conducted by firstly collecting viral proteins (except the ASFV) which interacted with swine proteins based on the database of Viruses.STRING. Then, 159 ASFV proteins encoded by BA71V, which were downloaded from NCBI RefSeq database (<xref rid="ref-45" ref-type="bibr">Pruitt, Tatusova &#x00026; Maglott, 2005</xref>), were blast (<xref rid="ref-4" ref-type="bibr">Altschul et al., 1990</xref>) against these viral proteins. The hits with <italic>e</italic>-value smaller than 0.001, coverage greater than 40%, and sequence identity greater than 30%, were considered as homologs of ASFV proteins. The swine proteins which interacted with the hits were predicted to interact with the ASFV proteins. The obtained three protein&#x02013;protein interactions overlapped with those from Viruses.STRING (<xref ref-type="supplementary-material" rid="supp-3">Table S1</xref>).</p></sec><sec><title>Swine protein&#x02013;protein interaction network</title><p>All the swine protein&#x02013;protein interactions were downloaded from STRING database (<xref rid="ref-53" ref-type="bibr">Szklarczyk et al., 2016</xref>) on 8 January 2019. Only the protein&#x02013;protein interactions with a median confidence (score greater than 0.4) were kept. Besides, the redundant protein&#x02013;protein interactions were removed. Finally, a protein&#x02013;protein interaction network which consisted of 731,174 non-redundant protein&#x02013;protein interactions between 18,683 swine proteins was obtained for further analysis.</p></sec><sec><title>Network analysis and visualization</title><p>The igraph package (version 1.2.2) (<xref rid="ref-14" ref-type="bibr">Csardi &#x00026; Nepusz, 2006</xref>) in R was used to analyze the topology of the protein&#x02013;protein interaction network. The degree and betweenness of proteins in the protein&#x02013;protein interaction network were calculated with the functions of <italic>degree()</italic> and <italic>betweenness()</italic>, respectively. The shortest path length between two proteins in the protein&#x02013;protein interaction network was calculated with the function of <italic>shortest.paths()</italic>.</p><p>The network was visualized with the help of Cytoscape (version 3.7.1) (<xref rid="ref-52" ref-type="bibr">Su et al., 2014</xref>).</p></sec><sec><title>Functional enrichment analysis</title><p>The Gene Ontology (GO) terms and KEGG pathway enrichment analysis for the ASFV-interacting swine proteins or the ASFV infection-associated swine proteins were conducted with functions of <italic>enrichGO()</italic> and <italic>enrichKEGG()</italic> in the package &#x0201c;clusterProfiler&#x0201d; (version 3.6.0) (<xref rid="ref-62" ref-type="bibr">Yu et al., 2012</xref>) in R (version 3.4.2). All the GO terms and KEGG pathways with adjusted <italic>p</italic>-values smaller than 0.01 were considered as significant enrichment (<xref ref-type="supplementary-material" rid="supp-4">Table S2</xref>).</p></sec><sec><title>Prediction of candidate drugs targeting ASFV and swine proteins</title><p>Candidate drugs were predicted with the help of DrugBank (version 5.1.2) (<xref rid="ref-60" ref-type="bibr">Wishart et al., 2018</xref>). The protein sequence of each ASFV protein encoded by BA71V, and that of each ASFV-Interacting swine Protein was queried against DrugBank for similar targets with the default parameters. The drugs targeting the best hit were considered to be candidate drugs for the query protein. The properties of drugs, such as the type and group of drug and ATC code, were also obtained from DrugBank (<xref ref-type="supplementary-material" rid="supp-5">Table S3</xref>).</p></sec><sec><title>Modeling the interaction between Geldanamycin and swine HSP90AB1</title><p>The 3D structure of swine HSP90AB1 was predicted using homology modeling method (<xref rid="ref-18" ref-type="bibr">Eswar et al., 2006</xref>). The modeling template was the crystal structure of the Geldanamycin-binding domain of a heat shock protein 90-alpha (HSP90AA1) from <italic>Homo sapiens</italic> (PDB code: 1YET). Sequence alignment showed that the identity between swine HSP90AB1 and human HSP90AA1 was 92.3% in the Geldanamycin-binding domain (208 residues). Besides, only amino acid substitutions but no gaps were observed in the alignment. The highly similar and gap-free alignment indicated that the predicted structure is reliable. In addition, 1YET is the complex structure of Geldanamycin and HSP90AA1, which allowed us to transfer the binding conformation of Geldanamycin from 1YET to the predicted structure of swine HSP90AB1. To validate the binding conformation between Geldanamycin and swine HSP90AB1, molecular dynamics (MD) simulation was performed for 10 ns using GROMACS (<xref rid="ref-1" ref-type="bibr">Abraham et al., 2015</xref>). The RMSDs (root mean square deviation) and binding energies of the complex between Geldanamycin and swine HSP90AB1 were calculated.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Interactions between ASFV and swine proteins</title><p>We firstly attempted to collect the interactions between ASFV and swine proteins as more as possible. In total, we obtained 44 protein&#x02013;protein interactions between them (<xref ref-type="fig" rid="fig-1">Fig. 1A</xref>), including 24 protein&#x02013;protein interactions from the database of Viruses.STRING, 20 protein&#x02013;protein interactions from the literature and three protein&#x02013;protein interactions inferred from protein to protein interactions between other viruses and swine based on sequence homology (details in &#x0201c;Materials and Methods&#x0201d;). A total of 16 ASFV proteins were involved in the protein&#x02013;protein interactions. Half of ASFV proteins interacted with only one swine protein. For the remaining half of ASFV proteins, the DNA-directed DNA polymerase interacted with 13 swine proteins, while the A179L and A238L both interacted with four swine proteins. Thirty-eight swine proteins were involved in the protein&#x02013;protein interactions between ASFV and swine, which were defined as ASFV-interacting swine proteins. All of them only interacted with one ASFV protein except the proteins of DNAJA3, FBXO2 and SNAPIN.</p><fig id="fig-1" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.8855/fig-1</object-id><label>Figure 1</label><caption><title>Overview of protein&#x02013;protein interactions between the ASFV and swine.</title><p>(A) Collected protein&#x02013;protein interactions between ASFV and swine proteins. AIP, ASFV-interacting swine proteins. (B) All the ASFV proteins involved in protein&#x02013;protein interactions and the number of interacted swine proteins. PPI, protein&#x02013;protein interaction.</p></caption><graphic xlink:href="peerj-08-8855-g001"/></fig></sec><sec><title>Construction of the ASFV-swine protein interaction network and topological analysis</title><p>To investigate the role of ASFV-interacting swine proteins in the swine, a swine protein&#x02013;protein interaction network was constructed from the STRING database, which contained 731,174 non-redundant protein&#x02013;protein interactions between 18,683 swine proteins. 35 (94%) ASFV-interacting swine proteins were found to interact with 4,184 other swine proteins. The latter 4,184 swine proteins were defined as ASFV infection-associated swine proteins. The ASFV-interacting swine proteins together with ASFV infection-associated swine proteins formed a protein interaction network with 9,305 non-redundant interactions (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>), including 68 interactions between ASFV-interacting swine proteins.</p><fig id="fig-2" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.8855/fig-2</object-id><label>Figure 2</label><caption><title>The protein&#x02013;protein interaction network between ASFV-interacting swine proteins and ASFV infection-associated proteins, and the topological analysis of these proteins.</title><p>(A) The protein&#x02013;protein interaction network between ASFV-interacting swine proteins (AIPs) and ASFV infection-associated proteins (AAPs). (B&#x02013;D) Distribution of the betweenness centrality, degree and shortest path length for all proteins (ALL), ASFV-interacting swine proteins (AIPs) and ASFV infection-associated swine proteins (AAPs) in the swine protein&#x02013;protein interaction network.</p></caption><graphic xlink:href="peerj-08-8855-g002"/></fig><p>To investigate the centrality of ASFV-interacting and ASFV infection-associated swine proteins in the swine protein&#x02013;protein interaction network, we calculated the degree and betweenness centrality, and the average shortest path length of each protein in the swine protein&#x02013;protein interaction network (<xref ref-type="fig" rid="fig-2">Figs. 2B</xref>&#x02013;<xref ref-type="fig" rid="fig-2">2D</xref>). The node (protein) degree was defined as the number of connections the node has to other nodes in the network; the node betweenness was defined as the number of shortest paths that pass through the node; the average shortest path length of a node was defined as the average length of all shortest paths from the node to other nodes. All of them measure the importance of a node in the network. The median degree and betweenness centrality, and the median shortest path length of all proteins in the swine protein&#x02013;protein interaction network were 32, 10<sup>3.5</sup> and 59.2, respectively, whereas these values for the ASFV-interacting swine proteins were 144, 10<sup>4.6</sup> and 58.7, respectively, and they were 120, 10<sup>4.2</sup> and 58.8, respectively, for the ASFV infection-associated swine proteins (<xref ref-type="fig" rid="fig-2">Fig. 2B</xref>). The ASFV-interacting swine proteins and ASFV infection-associated swine proteins were observed to have significant larger degrees and betweenness, and smaller shortest path length than all swine proteins, with <italic>p</italic>-values much smaller than 0.001 in the two-sided Wilcoxon rank-sum test. This suggested that the ASFV-interacting swine proteins and ASFV infection-associated swine proteins played a central role in the swine protein&#x02013;protein interaction network.</p></sec><sec><title>Functional analysis of ASFV-interacting swine proteins and ASFV infection-associated swine proteins</title><p>Since the ASFV-interacting swine proteins and ASFV infection-associated swine proteins were observed to play a central role in swine protein&#x02013;protein interaction network, we next investigated their functions. Functional enrichment analysis was conducted on the ASFV-interacting swine proteins and ASFV infection-associated swine proteins (<xref ref-type="supplementary-material" rid="supp-4">Table S2</xref>). Only a few GO terms in the domain of Molecular Function were enriched. Interestingly, nearly 50 KEGG pathways were enriched in the ASFV-interacting swine proteins (<xref ref-type="supplementary-material" rid="supp-4">Table S2</xref>). The pathways of Necroptosis and Alcoholism were two of the most enriched pathways, both of which included more than 20% of all ASFV-interacting swine proteins. Besides, three pathways related to virus infection, such as &#x0201c;Herpes simplex virus 1 infection&#x0201d;, were also enriched.</p><p>We further conducted the functional enrichment analysis on the ASFV infection-associated swine proteins. <xref ref-type="fig" rid="fig-3">Figures 3A</xref>&#x02013;<xref ref-type="fig" rid="fig-3">3D</xref> showed the top ten GO terms in three domains of GO and KEGG pathways enriched in the ASFV infection-associated swine proteins. In the domain of Biological Process, six of top 10 enriched GO terms were related to cell death or apoptotic process; in the domain of Cellular Component, the ASFV infection-associated swine proteins were enriched in the nuclear and cytoskeleton; in the domain of Molecular Function, the ASFV infection-associated swine proteins were enriched in the GO terms of binding and enzyme activity. For the KEGG pathways, &#x0201c;Herpes simplex virus 1 infection&#x0201d; was most enriched. Besides, several signaling pathways were also enriched, such as &#x0201c;PI3K&#x02212;Akt signaling pathway&#x0201d; and &#x0201c;MAPK signaling pathway&#x0201d;.</p><fig id="fig-3" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.8855/fig-3</object-id><label>Figure 3</label><caption><title>Functional enrichment analysis of AAPs.</title><p>(A&#x02013;D) Top 10 enriched terms in the domain of biological process, cellular component and molecular function and KEGG pathways were shown.</p></caption><graphic xlink:href="peerj-08-8855-g003"/></fig></sec><sec><title>The role of ASFV-interacting swine proteins in the protein&#x02013;protein interactions between swine and other viruses</title><p>We then investigated the role of ASFV-interacting swine proteins in the protein&#x02013;protein interactions between swine and other viruses. All the protein&#x02013;protein interactions between ASFV-interacting swine proteins and other viral proteins which were public available in the Viruses.STRING database were obtained. As was shown in <xref ref-type="fig" rid="fig-4">Fig. 4A</xref>, 48 protein&#x02013;protein interactions were obtained and shaped a network, which included 15 proteins from 11 other viruses (nodes in square) and 16 ASFV-interacting swine proteins (nodes in ellipse). A total of 13 ASFV-interacting swine proteins were observed to interact with more than one other virus. Besides, they also interacted with several hundreds of proteins in the swine protein&#x02013;protein interaction network (<xref ref-type="fig" rid="fig-4">Fig. 4B</xref>). For example, the heat shock protein 90 s, including HSP90AB1, HSP90AA1 and HSP90B1, could interact with proteins from other five viruses, and interact with more than 1,500 swine proteins, suggesting their central roles in both the virus-swine protein&#x02013;protein interaction network and swine protein&#x02013;protein interaction network.</p><fig id="fig-4" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.8855/fig-4</object-id><label>Figure 4</label><caption><title>ASFV-interacting swine proteins and their interactions with other viruses.</title><p>(A) The protein&#x02013;protein interaction network between ASFV-interacting swine proteins (AIPs) and other viruses. ASFV-interacting swine proteins were represented as ellipse in gray. Viruses were represented as squares and colored according to the legend in the bottom right. VESE, Vesicular exanthema of swine virus; Swinepox, Swinepox virus; TTSV1a, Torque teno sus virus 1a; TeschoA, Teschovirus A; Nodamura, Nodamura virus; FMDV, Foot-and-mouth disease virus; TTSVk2, Torque teno sus virus k2; FLUCV, Influenza C virus; EMCV, Encephalomyocarditis virus. (B) The number of interacted virus and the degree of ASFV-interacting swine proteins in the swine protein&#x02013;protein interaction network. HISTH2AC, histone H2A type 2-C; H2A1-H, histone H2A type 1-H; HIST1H2AA, histone H2A type 1-A; HIST1H2AJ, histone H2A type 1-like; H2A2-A-L, histone H2A type 2-A-like; H2AFX, histone H2AX.</p></caption><graphic xlink:href="peerj-08-8855-g004"/></fig></sec><sec><title>Drug prediction for treating ASFVs</title><p>The wide involvement of ASFV-interacting swine proteins in protein&#x02013;protein interactions between swine and multiple viruses, and the central role of ASFV-interacting swine proteins in swine protein&#x02013;protein interaction network, suggested the possibility of their use as broad-spectrum host-dependent antiviral drug targets. Therefore, we attempted to predict drugs targeting the ASFV-interacting swine proteins with the help of DrugBank (<xref ref-type="supplementary-material" rid="supp-5">Table S3</xref>). As was shown in <xref ref-type="fig" rid="fig-5">Fig. 5A</xref> total of 142 drugs (in ellipse or square) were predicted to target 21 ASFV-interacting swine proteins (pink circles). Most of the drugs were small molecules (colored ellipses); the other drugs were protein or peptide (colored squares). Some ASFV-interacting swine proteins were targeted by multiple drugs, such as the heat shock protein 90 alpha family class A member 1 (HSP90AA1) and tumor necrosis factor (TNF). HSP90AA1 was targeted by more than 30 drugs, most of which were small molecules and were in experimental; while TNF were also targeted by more than 30 drugs, most of which were approved or investigational.</p><fig id="fig-5" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.8855/fig-5</object-id><label>Figure 5</label><caption><title>Predicted drugs targeting the ASFV-interacting swine proteins (AIPs) and ASFV proteins.</title><p>The interactions above and below the dotted line referred to those between drugs and ASFV-interacting swine proteins, and those between drugs and ASFV proteins, respectively. The ASFV-interacting swine proteins and ASFV proteins were represented as red and cyan circles, respectively. Drugs of protein or peptide, and those of small molecule, were represented as squares and ellipses, respectively. Drugs in the stage of approved, investigational and experimental were colored in orange, purple and light green, respectively. Drugs which specifically targeted one ASFV-interacting swine protein were highlighted in black-edge. Two drugs which targeted both the ASFV-interacting swine protein and ASFV protein were highlighted in red-edge.</p></caption><graphic xlink:href="peerj-08-8855-g005"/></fig><p>We also predicted drugs targeting the ASFV proteins. Twenty-nine small molecules were predicted to target 10 ASFV proteins. Among them, both the proteins of F778R and A240L were targeted by eight drugs. However, these ten ASFV proteins were not involved in the protein&#x02013;protein interactions between ASFV and swine. Interestingly, the Gallium nitrate (DrugBank ID: DB05260), a drug used for treating hyper-calcemia and Rifabutin (DrugBank ID: DB00615), a antibiotic with potent antimycobacterial properties, were observed to both target the ASFV-interacting swine proteins and ASFV proteins. Both of them (highlighted in red-edge) were approved for use, suggesting their potential use for treating the ASFVs.</p><p>Some drugs were observed to have strong specificity on the ASFV protein or ASFV-interacting swine proteins, such as the Hydroxyurea (DB01005), Infliximab (DB00065), Adalimumab (DB00051) and so on. Hydroxyurea specifically targeted F778R. It is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. It may be used to inhibit DNA synthesis of the ASFV virus, thus blocking the proliferation of the virus. Infliximab specifically targeted TNF and is primarily related to inflammation control and neurological indications. It may be used to block the necrosis during the ASFV infection.</p><p>Some drugs were observed to target multiple ASFV-interacting swine proteins, such as Geldanamycin (DB02424), Polaprezinc (DB09221) and Andrographolide (DB05767). For example, Geldanamycin could target the HSP90AA1, HSP90AB1 and HSP90B1, all of which played a central role in the swine protein&#x02013;protein interaction network and swine-virus protein&#x02013;protein interaction network (<xref ref-type="fig" rid="fig-4">Fig. 4B</xref>). This suggested that Geldanamycin may have a broad-spectrum effect in disrupting the swine-ASFV protein&#x02013;protein interaction network, and may inhibit the viral infections effectively. Therefore, we further investigated the mechanism of Geldanamycin by modeling the interactions between Geldanamycin and swine HSP90AB1 (<xref ref-type="fig" rid="fig-6">Fig. 6</xref>). The 3D structure of the Geldanamycin-binding domain of swine HSP90AB1 was modeled using the template of human HSP90AA1 (PDB code: 1YET). The binding conformation of Geldanamycin was also predicted by referring the same compound in the template structure (<xref ref-type="fig" rid="fig-6">Fig. 6A</xref>) (see &#x0201c;Methods&#x0201d;). As the sequence identity between the template and swine HSP90AB1 was as high as 92.8%, particularly in the ligand-binding regions, their binding modes with Geldanamycin in two structures should be highly similar. MD was performed for the complex structure of Geldanamycin and swine HSP90AB1 to investigate their interactions. The result showed that the RMSD (root mean square deviation) of Geldanamycin and swine HSP90AB1 were less than 1.6 &#x000c5; in the 10 ns simulation (<xref ref-type="fig" rid="fig-6">Fig. 6B</xref>), which indicated the binding conformation was highly stable. The key contributions of binding energy were from ASN51, ASP54, LYS58, ASP93, MET98, ASP102, ASN106, PHE138 and THR184, which was almost identical to the template (<xref ref-type="supplementary-material" rid="supp-1">Fig. S1</xref>). In addition, the binding free energy for swine HSP90AB1 and Geldanamycin complex structures was &#x02212;76.8 kcal/mol which was even stronger than &#x02212;69.1 kcal/mol of the template (<xref ref-type="supplementary-material" rid="supp-2">Fig. S2</xref>). Hence, Geldanamycin could bind with swine HSP90AB1, similar to that in <italic>Homo sapiens</italic>.</p><fig id="fig-6" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.8855/fig-6</object-id><label>Figure 6</label><caption><title>Modelling the interactions between Geldanamycin and swine HSP90AB1.</title><p>(A) The predicted 3D structure of the Geldanamycin-binding domain of swine HSP90AB1 and its interaction with Geldanamycin. (B) RMSD of all C&#x003b1; atoms for the ligand (black) and receptor-ligand complex (red) during MD simulations (10 ns).</p></caption><graphic xlink:href="peerj-08-8855-g006"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Vaccines and antiviral-drugs are considered as the most effective tools for fighting against viruses. Unfortunately, nearly all attempts to develop vaccines against ASFVs have failed to induce effective protection (<xref rid="ref-59" ref-type="bibr">Wang et al., 2018</xref>). Therefore, it is necessary to develop antiviral drugs against the virus. Previous studies have found several antiviral drugs which could possibly inhibit ASFV infection in vitro (<xref rid="ref-6" ref-type="bibr">Arabyan et al., 2019</xref>), including nucleoside analogs (<xref rid="ref-8" ref-type="bibr">Berry &#x00026; Kinsella, 2001</xref>), genistein (<xref rid="ref-5" ref-type="bibr">Arabyan et al., 2018</xref>), genkwanin (<xref rid="ref-28" ref-type="bibr">Hakobyan et al., 2019</xref>), Rifampicin (<xref rid="ref-15" ref-type="bibr">Dardiri, Bachrach &#x00026; Heller, 1971</xref>), fluoroquinolone (<xref rid="ref-42" ref-type="bibr">Mottola et al., 2013</xref>), sulfated polysaccharides (<xref rid="ref-24" ref-type="bibr">Garc&#x000ed;a-Villal&#x000f3;n &#x00026; Gil-Fern&#x000e1;ndez, 1991</xref>), lauryl gallate (<xref rid="ref-34" ref-type="bibr">Hurtado et al., 2008</xref>), stilbenes resveratrol (<xref rid="ref-23" ref-type="bibr">Galindo et al., 2011</xref>), oxyresveratrol (<xref rid="ref-23" ref-type="bibr">Galindo et al., 2011</xref>), histone deacetylases enzymes (HDACs) inhibitor (<xref rid="ref-20" ref-type="bibr">Frouco et al., 2017</xref>), small peptide inhibitors (<xref rid="ref-33" ref-type="bibr">Hern&#x000e1;ez et al., 2010</xref>) and so on. This study computationally predicted several candidate drugs targeting the ASFV proteins and ASFV-interacting swine proteins, which may be helpful for the development of more effective drugs against the ASFV.</p><p>In the era of systems biology, a large amount of protein&#x02013;protein interactions have been accumulated, including the virus-host protein&#x02013;protein interactions. This study compiled an up-to-date protein&#x02013;protein interaction network between ASFV and swine. Analysis of the network could help identify possible associations between viral activities and host defense strategies, which may facilitate development of potential therapies by disrupting host-virus interactions (<xref rid="ref-56" ref-type="bibr">Tan et al., 2007</xref>). Several ASFV-interacting swine proteins and lots of ASFV infection-associated swine proteins were identified based on the protein&#x02013;protein interaction network. They were observed to interact with more proteins or have larger influences on the information flow throughout the swine protein&#x02013;protein interaction network than other proteins, suggesting their central roles in the swine protein&#x02013;protein interaction network. Some ASFV-interacting swine proteins were observed to interact with multiple viruses. They could be used as antiviral drug targets. Besides, the predicted drugs targeting these ASFV-interacting swine proteins, such as Polaprezinc and Geldanamycin, may have a broad-spectrum effect against viral infections.</p><p>Both the ASFV-interacting swine proteins and ASFV infection-associated swine proteins were enriched in the functions of cell death, apoptosis or necroptosis. This suggested that these processes may play an important role in viral infections. Previous studies have shown that ASFV infection induced TNF-alpha production which further induced apoptosis in the infected cell (<xref rid="ref-16" ref-type="bibr">Del Moral et al., 1999</xref>). Actually, ASFV induced apoptosis of infected cells both in vitro and in vivo (<xref rid="ref-46" ref-type="bibr">Ramiro-Ib&#x000e1;&#x000f1;ez et al., 1996</xref>). ASFV has several strategies to regulate apoptosis. It encodes several anti-apoptotic proteins such as A179L and A224L to delay the execution step of the apoptotic pathway. The virus also has the capacity of regulating the unfolded protein response to prevent early apoptosis and ensure viral replication (<xref rid="ref-22" ref-type="bibr">Galindo et al., 2012</xref>). In the late stage of ASFV infection, induction of apoptosis could favor virus spread without the activation of inflammatory responses (<xref rid="ref-11" ref-type="bibr">Carrascosa et al., 2002</xref>). Therefore, the drugs which could inhibit cell death, apoptosis or necroptosis, may be candidates for treatment of ASFVs. For example, the infliximab, which is a TNF blocker and primarily related to inflammation control (<xref rid="ref-35" ref-type="bibr">Keane et al., 2001</xref>), may be used to block the necrosis during the ASFV infection.</p><p>Lots of drugs were predicted to target the ASFV-interacting swine proteins or ASFV proteins. Several strategies could be used to select the candidate drugs. For specificity, the drugs with high specificity on the ASFV-interacting swine proteins or ASFV proteins could be selected, such as the Hydroxyurea and Infliximab; for broad-spectrum effect, the drugs which targeted the ASFV-interacting swine proteins with high degrees in the swine protein&#x02013;protein interaction network, such as Polaprezinc, or those which targeted multiple ASFV-interacting swine proteins, such as Geldanamycin, could have a large influence on the protein&#x02013;protein interactions between swine and ASFV. Two drugs, that is, Gallium nitrate and Rifabutin, were observed to target both the ASFV-interacting swine proteins and ASFV proteins. They could also be used for broad-spectrum inhibitory effect against ASFV infections.</p><p>Most antiviral drugs target the viral proteins. Drug resistance frequently appears due to rapid mutation of viruses. On the contrary, the drugs targeting the host protein may have the advantage of stable effect since the host proteins generally evolve far slower than viral proteins (<xref rid="ref-31" ref-type="bibr">He, Duan &#x00026; Tan, 2007</xref>; <xref rid="ref-57" ref-type="bibr">Tavassoli, 2011</xref>). Besides, some host proteins may interact with multiple viruses, such as HSP90AB1 mentioned above. The drugs targeting them may have broad-spectrum antiviral effect. Bioinformatics analysis of the accumulated protein&#x02013;protein interactions between virus and host cell can facilitate the identification host proteins which are vital for viral infection. As the accumulation of protein&#x02013;protein interactions and the rapid development of bioinformatics methods, several antiviral molecules with reduced side effects have been proposed and validated (<xref rid="ref-51" ref-type="bibr">Sessions et al., 2009</xref>). Previous studies have developed antiviral drugs against the host proteins such as the ubiquitin-proteasome system (<xref rid="ref-7" ref-type="bibr">Barrado-Gil et al., 2017</xref>) and HDACs (<xref rid="ref-20" ref-type="bibr">Frouco et al., 2017</xref>) to inhibit the replication of ASFVs. This study investigated the prediction of antiviral drugs against ASFV infections. The ASFV-interacting swine proteins could be taken as potential antiviral-drug targets. The candidate drugs identified here may facilitate further development of effective drugs against the virus.</p><p>There were two limitations to this study. Firstly, the protein&#x02013;protein interactions between swine and ASFV are far from complete. The ASFV encodes more than 150 proteins (<xref rid="ref-49" ref-type="bibr">Rodr&#x000ed;guez &#x00026; Salas, 2013</xref>). Only 16 of them were involved in the protein&#x02013;protein interactions analyzed here. Much more efforts are needed to generate a comprehensive protein&#x02013;protein interaction network between swine and ASFV. Fortunately, based on the limited protein&#x02013;protein interactions between swine and ASFV, several antiviral drugs were predicted and had the potential for further development. Secondly, the drugs predicted here need further experimental validations. Several drugs with high specificity on ASFV-interacting swine proteins, or with broad-spectrum effect, such as Polaprezinc and Geldanamycin, could be prioritized for validation.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In conclusion, this study curated an up-to-date set of protein&#x02013;protein interactions between swine and ASFV as far as we know, and identified the ASFV-interacting swine proteins which were vital for viral infection. The ASFV-interacting swine proteins were observed to play a central role in swine protein&#x02013;protein interaction network, and also took part in interactions between swine and several other viruses. They could be taken as potential antiviral-drug targets. Several drugs were predicted to target the ASFV-interacting swine proteins and ASFV proteins. They could be helpful for further development of effective drugs against the virus.</p></sec><sec sec-type="supplementary-material" id="supplemental-information"><title>Supplemental Information</title><supplementary-material content-type="local-data" id="supp-1"><object-id pub-id-type="doi">10.7717/peerj.8855/supp-1</object-id><label>Supplemental Information 1</label><caption><title>Contribution energy for each residue in the template (A) and modeled complex between Geldanamycin and swine HSP90AB1 (B).</title><p>MM: contains Van der Waals, electrostatic interactions, and net non-bonded potential energy between the protein and inhibitor; Polar: polar solvation energy; Apolar: non-polar solvation energy; Total: total energy.</p></caption><media xlink:href="peerj-08-8855-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-2"><object-id pub-id-type="doi">10.7717/peerj.8855/supp-2</object-id><label>Supplemental Information 2</label><caption><title>Binding energy of receptor-ligand complex for the template (A) and modeled complex between Geldanamycin and swine HSP90AB1 (B) during MD simulations (10 ns).</title><p>&#x00394;E<sub>vdw</sub> refer to Van der Waal energy, &#x00394;E<sub>elec</sub> refer to electrostatic energy, &#x00394;E<sub>mm</sub> refer to total potential energy between the protein and ligand (&#x00394;E<sub>mm =</sub> &#x00394;E<sub>vdw +</sub> &#x00394;E<sub>elec</sub>), &#x00394;E<sub>pol</sub> refer to polar solvation energy, &#x00394;E<sub>apol</sub> refer to non-polar solvation energy and &#x00394;E<sub>binding</sub> refer to the total binding energy (&#x00394;E<sub>binding =</sub> &#x00394;E<sub>mm +</sub> &#x00394;E<sub>pol +</sub> &#x00394;E<sub>apol</sub>).</p></caption><media xlink:href="peerj-08-8855-s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-3"><object-id pub-id-type="doi">10.7717/peerj.8855/supp-3</object-id><label>Supplemental Information 3</label><caption><title>The curated PPIs between ASFV and swine.</title></caption><media xlink:href="peerj-08-8855-s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-4"><object-id pub-id-type="doi">10.7717/peerj.8855/supp-4</object-id><label>Supplemental Information 4</label><caption><title>The enriched GO terms and KEGG pathways for AIPs and AAPs.</title></caption><media xlink:href="peerj-08-8855-s004.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-5"><object-id pub-id-type="doi">10.7717/peerj.8855/supp-5</object-id><label>Supplemental Information 5</label><caption><title>The predicted drugs targeting the AIPs and ASFV proteins.</title></caption><media xlink:href="peerj-08-8855-s005.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-6"><object-id pub-id-type="doi">10.7717/peerj.8855/supp-6</object-id><label>Supplemental Information 6</label><caption><title>Raw data for <xref ref-type="fig" rid="fig-6">Figure 6</xref>.</title></caption><media xlink:href="peerj-08-8855-s006.7z"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><sec sec-type="additional-information"><title>Additional Information and Declarations</title><fn-group content-type="competing-interests"><title>Competing Interests</title><fn fn-type="COI-statement" id="conflict-1"><p>The authors declare that they have no competing interests.</p></fn></fn-group><fn-group content-type="author-contributions"><title>Author Contributions</title><fn fn-type="con" id="contribution-1"><p><xref ref-type="contrib" rid="author-1">Zhaozhong Zhu</xref> performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.</p></fn><fn fn-type="con" id="contribution-2"><p><xref ref-type="contrib" rid="author-2">Yunshi Fan</xref> performed the experiments, prepared figures and/or tables, and approved the final draft.</p></fn><fn fn-type="con" id="contribution-3"><p><xref ref-type="contrib" rid="author-3">Yang Liu</xref> analyzed the data, prepared figures and/or tables, and approved the final draft.</p></fn><fn fn-type="con" id="contribution-4"><p><xref ref-type="contrib" rid="author-4">Taijiao Jiang</xref> conceived and designed the experiments, authored or reviewed drafts of the paper, and approved the final draft.</p></fn><fn fn-type="con" id="contribution-5"><p><xref ref-type="contrib" rid="author-5">Yang Cao</xref> performed the experiments, prepared figures and/or tables, and approved the final draft.</p></fn><fn fn-type="con" id="contribution-6"><p><xref ref-type="contrib" rid="author-6">Yousong Peng</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.</p></fn></fn-group><fn-group content-type="other"><title>Data Availability</title><fn id="addinfo-1"><p>The following information was supplied regarding data availability:</p><p>The raw measurements are available in the <xref ref-type="supplementary-material" rid="supplemental-information">Supplemental Files</xref>.</p></fn></fn-group></sec><ref-list content-type="authoryear"><title>References</title><ref id="ref-1"><label>Abraham et al. (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>MJ</given-names></name><name><surname>Murtola</surname><given-names>T</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>P&#x000e1;ll</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Lindahl</surname><given-names>E</given-names></name></person-group><article-title>GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><year>2015</year><volume>1&#x02013;2</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id></element-citation></ref><ref id="ref-2"><label>Alonso et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Borca</surname><given-names>M</given-names></name><name><surname>Dixon</surname><given-names>L</given-names></name><name><surname>Revilla</surname><given-names>Y</given-names></name><name><surname>Rodriguez</surname><given-names>F</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><collab><institution>ICTV Report Consortium</institution></collab></person-group><article-title>ICTV virus taxonomy profile: <italic>Asfarviridae</italic></article-title><source>Journal of General Virology</source><year>2018</year><volume>99</volume><issue>5</issue><fpage>613</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">29565243</pub-id></element-citation></ref><ref id="ref-3"><label>Alonso et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Miskin</surname><given-names>J</given-names></name><name><surname>Hern&#x000e1;ez</surname><given-names>B</given-names></name><name><surname>Fernandez-Zapatero</surname><given-names>P</given-names></name><name><surname>Soto</surname><given-names>L</given-names></name><name><surname>Cant&#x000f3;</surname><given-names>C</given-names></name><name><surname>Rodr&#x000ed;guez-Crespo</surname><given-names>I</given-names></name><name><surname>Dixon</surname><given-names>L</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name></person-group><article-title>African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein</article-title><source>Journal of Virology</source><year>2001</year><volume>75</volume><fpage>9819</fpage><lpage>9827</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.20.9819-9827.2001</pub-id><pub-id pub-id-type="pmid">11559815</pub-id></element-citation></ref><ref id="ref-4"><label>Altschul et al. (1990)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic local alignment search tool</article-title><source>Journal of Molecular Biology</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">2231712</pub-id></element-citation></ref><ref id="ref-5"><label>Arabyan et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabyan</surname><given-names>E</given-names></name><name><surname>Hakobyan</surname><given-names>A</given-names></name><name><surname>Kotsinyan</surname><given-names>A</given-names></name><name><surname>Karalyan</surname><given-names>Z</given-names></name><name><surname>Arakelov</surname><given-names>V</given-names></name><name><surname>Arakelov</surname><given-names>G</given-names></name><name><surname>Nazaryan</surname><given-names>K</given-names></name><name><surname>Simonyan</surname><given-names>A</given-names></name><name><surname>Aroutiounian</surname><given-names>R</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name><name><surname>Zakaryan</surname><given-names>H</given-names></name></person-group><article-title>Genistein inhibits African swine fever virus replication in vitro by disrupting viral DNA synthesis</article-title><source>Antiviral Research</source><year>2018</year><volume>156</volume><fpage>128</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2018.06.014</pub-id><pub-id pub-id-type="pmid">29940214</pub-id></element-citation></ref><ref id="ref-6"><label>Arabyan et al. (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabyan</surname><given-names>E</given-names></name><name><surname>Kotsynyan</surname><given-names>A</given-names></name><name><surname>Hakobyan</surname><given-names>A</given-names></name><name><surname>Zakaryan</surname><given-names>H</given-names></name></person-group><article-title>Antiviral agents against African swine fever virus</article-title><source>Virus Research</source><year>2019</year><volume>270</volume><fpage>197669</fpage><pub-id pub-id-type="doi">10.1016/j.virusres.2019.197669</pub-id><pub-id pub-id-type="pmid">31325472</pub-id></element-citation></ref><ref id="ref-7"><label>Barrado-Gil et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrado-Gil</surname><given-names>L</given-names></name><name><surname>Galindo</surname><given-names>I</given-names></name><name><surname>Martinez-Alonso</surname><given-names>D</given-names></name><name><surname>Viedma</surname><given-names>S</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>The ubiquitin-proteasome system is required for African swine fever replication</article-title><source>PLOS ONE</source><year>2017</year><volume>12</volume><issue>12</issue><elocation-id>e0189741</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0189741</pub-id><pub-id pub-id-type="pmid">29244872</pub-id></element-citation></ref><ref id="ref-8"><label>Berry &#x00026; Kinsella (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>SE</given-names></name><name><surname>Kinsella</surname><given-names>TJ</given-names></name></person-group><article-title>Targeting DNA mismatch repair for radiosensitization</article-title><source>Seminars in Radiation Oncology</source><year>2001</year><volume>11</volume><issue>4</issue><fpage>300</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1053/S1053-4296(01)80067-9</pub-id><pub-id pub-id-type="pmid">11677655</pub-id></element-citation></ref><ref id="ref-9"><label>Borca et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borca</surname><given-names>MV</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>V</given-names></name><name><surname>Holinka</surname><given-names>LG</given-names></name><name><surname>Rai</surname><given-names>DK</given-names></name><name><surname>Sanford</surname><given-names>B</given-names></name><name><surname>Alfano</surname><given-names>M</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Azzinaro</surname><given-names>PA</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Gladue</surname><given-names>DP</given-names></name></person-group><article-title>The Ep152R ORF of African swine fever virus strain Georgia encodes for an essential gene that interacts with host protein BAG6</article-title><source>Virus Research</source><year>2016</year><volume>223</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">27497620</pub-id></element-citation></ref><ref id="ref-10"><label>Brun et al. (1996)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brun</surname><given-names>A</given-names></name><name><surname>Rivas</surname><given-names>C</given-names></name><name><surname>Esteban</surname><given-names>M</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>African swine fever virus gene <italic>A179L</italic>, a viral homologue of <italic>bcl</italic>-2, protects cells from programmed cell death</article-title><source>Virology</source><year>1996</year><volume>225</volume><issue>1</issue><fpage>227</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1006/viro.1996.0592</pub-id><pub-id pub-id-type="pmid">8918551</pub-id></element-citation></ref><ref id="ref-11"><label>Carrascosa et al. (2002)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrascosa</surname><given-names>AL</given-names></name><name><surname>Bustos</surname><given-names>MJ</given-names></name><name><surname>Nogal</surname><given-names>ML</given-names></name><name><surname>De Buitrago</surname><given-names>GG</given-names></name><name><surname>Revilla</surname><given-names>Y</given-names></name></person-group><article-title>Apoptosis induced in an early step of African swine fever virus entry into vero cells does not require virus replication</article-title><source>Virology</source><year>2002</year><volume>294</volume><fpage>372</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1006/viro.2001.1348</pub-id><pub-id pub-id-type="pmid">12009879</pub-id></element-citation></ref><ref id="ref-12"><label>Cook et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>HV</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Von Mering</surname><given-names>C</given-names></name><name><surname>Jensen</surname><given-names>L</given-names></name></person-group><article-title>Viruses.STRING: a virus-host protein&#x02013;protein interaction database</article-title><source>Viruses</source><year>2018</year><volume>10</volume><issue>10</issue><fpage>519</fpage></element-citation></ref><ref id="ref-13"><label>Costard et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costard</surname><given-names>S</given-names></name><name><surname>Jones</surname><given-names>BA</given-names></name><name><surname>Martinez-Lopez</surname><given-names>B</given-names></name><name><surname>Mur</surname><given-names>L</given-names></name><name><surname>De la Torre</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>M</given-names></name><name><surname>S&#x000e1;nchez-Vizca&#x000ed;no</surname><given-names>F</given-names></name><name><surname>Sanchez-Vizcaino</surname><given-names>J-M</given-names></name><name><surname>Pfeiffer</surname><given-names>DU</given-names></name><name><surname>Wieland</surname><given-names>B</given-names></name></person-group><article-title>Introduction of African swine fever into the European Union through illegal importation of pork and pork products</article-title><source>PLOS ONE</source><year>2013</year><volume>8</volume><issue>4</issue><elocation-id>e61104</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061104</pub-id><pub-id pub-id-type="pmid">23613795</pub-id></element-citation></ref><ref id="ref-14"><label>Csardi &#x00026; Nepusz (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csardi</surname><given-names>G</given-names></name><name><surname>Nepusz</surname><given-names>T</given-names></name></person-group><article-title>The igraph software package for complex network research</article-title><source>InterJournal, Complex Systems</source><year>2006</year><volume>1695</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="ref-15"><label>Dardiri, Bachrach &#x00026; Heller (1971)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dardiri</surname><given-names>AH</given-names></name><name><surname>Bachrach</surname><given-names>HL</given-names></name><name><surname>Heller</surname><given-names>E</given-names></name></person-group><article-title>Inhibition by rifampin of African swine fever virus replication in tissue culture</article-title><source>Infection and Immunity</source><year>1971</year><volume>4</volume><issue>1</issue><fpage>34</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">5154875</pub-id></element-citation></ref><ref id="ref-16"><label>Del Moral et al. (1999)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Moral</surname><given-names>MG</given-names></name><name><surname>Ortuno</surname><given-names>E</given-names></name><name><surname>Fernandez-Zapatero</surname><given-names>P</given-names></name><name><surname>Alonso</surname><given-names>F</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Ezquerra</surname><given-names>A</given-names></name><name><surname>Dominguez</surname><given-names>J</given-names></name></person-group><article-title>African swine fever virus infection induces tumor necrosis factor alpha production: implications in pathogenesis</article-title><source>Journal of Virology</source><year>1999</year><volume>73</volume><issue>3</issue><fpage>2173</fpage><lpage>2180</lpage><pub-id pub-id-type="pmid">9971800</pub-id></element-citation></ref><ref id="ref-17"><label>Esparza, Gonz&#x000e1;lez &#x00026; Vi&#x000f1;uela (1988)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esparza</surname><given-names>I</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>JC</given-names></name><name><surname>Vi&#x000f1;uela</surname><given-names>E</given-names></name></person-group><article-title>Effect of interferon-&#x003b1;, interferon-&#x003b3; and tumour necrosis factor on African swine fever virus replication in porcine monocytes and macrophages</article-title><source>Journal of General Virology</source><year>1988</year><volume>69</volume><fpage>2973</fpage><lpage>2980</lpage><pub-id pub-id-type="pmid">3143809</pub-id></element-citation></ref><ref id="ref-18"><label>Eswar et al. (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eswar</surname><given-names>N</given-names></name><name><surname>Webb</surname><given-names>B</given-names></name><name><surname>Marti-Renom</surname><given-names>MA</given-names></name><name><surname>Madhusudhan</surname><given-names>M</given-names></name><name><surname>Eramian</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>M-Y</given-names></name><name><surname>Pieper</surname><given-names>U</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name></person-group><article-title>Comparative protein structure modeling using modeller</article-title><source>Current Protocols in Bioinformatics</source><year>2006</year><volume>5</volume><issue>6</issue><fpage>5.6.1</fpage><lpage>5.6.30</lpage><pub-id pub-id-type="pmid">18428766</pub-id></element-citation></ref><ref id="ref-19"><label>Freitas et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitas</surname><given-names>FB</given-names></name><name><surname>Frouco</surname><given-names>G</given-names></name><name><surname>Martins</surname><given-names>C</given-names></name><name><surname>Leitao</surname><given-names>A</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name></person-group><article-title>In vitro inhibition of African swine fever virus-topoisomerase II disrupts viral replication</article-title><source>Antiviral Research</source><year>2016</year><volume>134</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2016.08.021</pub-id><pub-id pub-id-type="pmid">27568922</pub-id></element-citation></ref><ref id="ref-20"><label>Frouco et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frouco</surname><given-names>G</given-names></name><name><surname>Freitas</surname><given-names>FB</given-names></name><name><surname>Martins</surname><given-names>C</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name></person-group><article-title>Sodium phenylbutyrate abrogates African swine fever virus replication by disrupting the virus-induced hypoacetylation status of histone H3K9/K14</article-title><source>Virus Research</source><year>2017</year><volume>242</volume><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2017.09.009</pub-id><pub-id pub-id-type="pmid">28916365</pub-id></element-citation></ref><ref id="ref-21"><label>Galindo et al. (2008)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo</surname><given-names>I</given-names></name><name><surname>Hernaez</surname><given-names>B</given-names></name><name><surname>D&#x000ed;az-Gil</surname><given-names>G</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>A179L, a viral Bcl-2 homologue, targets the core Bcl-2 apoptotic machinery and its upstream BH3 activators with selective binding restrictions for Bid and Noxa</article-title><source>Virology</source><year>2008</year><volume>375</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2008.01.050</pub-id><pub-id pub-id-type="pmid">18329683</pub-id></element-citation></ref><ref id="ref-22"><label>Galindo et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo</surname><given-names>I</given-names></name><name><surname>Hernaez</surname><given-names>B</given-names></name><name><surname>Munoz-Moreno</surname><given-names>R</given-names></name><name><surname>Cuesta-Geijo</surname><given-names>M</given-names></name><name><surname>Dalmau-Mena</surname><given-names>I</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>The ATF6 branch of unfolded protein response and apoptosis are activated to promote African swine fever virus infection</article-title><source>Cell Death &#x00026; Disease</source><year>2012</year><volume>3</volume><issue>7</issue><elocation-id>e341</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2012.81</pub-id><pub-id pub-id-type="pmid">22764100</pub-id></element-citation></ref><ref id="ref-23"><label>Galindo et al. (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo</surname><given-names>I</given-names></name><name><surname>Hern&#x000e1;ez</surname><given-names>B</given-names></name><name><surname>Bern&#x000e1;</surname><given-names>J</given-names></name><name><surname>Fenoll</surname><given-names>J</given-names></name><name><surname>Cenis</surname><given-names>J</given-names></name><name><surname>Escribano</surname><given-names>J</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>Comparative inhibitory activity of the stilbenes resveratrol and oxyresveratrol on African swine fever virus replication</article-title><source>Antiviral Research</source><year>2011</year><volume>91</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2011.04.013</pub-id><pub-id pub-id-type="pmid">21557969</pub-id></element-citation></ref><ref id="ref-24"><label>Garc&#x000ed;a-Villal&#x000f3;n &#x00026; Gil-Fern&#x000e1;ndez (1991)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Villal&#x000f3;n</surname><given-names>D</given-names></name><name><surname>Gil-Fern&#x000e1;ndez</surname><given-names>C</given-names></name></person-group><article-title>Antiviral activity of sulfated polysaccharides against African swine fever virus</article-title><source>Antiviral Research</source><year>1991</year><volume>15</volume><issue>2</issue><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(91)90031-L</pub-id><pub-id pub-id-type="pmid">1713439</pub-id></element-citation></ref><ref id="ref-25"><label>Gil-Fern&#x000e1;ndez et al. (1987)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-Fern&#x000e1;ndez</surname><given-names>C</given-names></name><name><surname>Garc&#x000ed;a-Villal&#x000f3;n</surname><given-names>D</given-names></name><name><surname>De Clercq</surname><given-names>E</given-names></name><name><surname>Rosenberg</surname><given-names>I</given-names></name><name><surname>Hol&#x000fd;</surname><given-names>A</given-names></name></person-group><article-title>Phosphonylmethoxyalkylpurines and-pyrimidines as inhibitors of African swine fever virus replication in vitro</article-title><source>Antiviral Research</source><year>1987</year><volume>8</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">3451699</pub-id></element-citation></ref><ref id="ref-26"><label>Gil-Fern&#x000e1;ndez et al. (1979)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-Fern&#x000e1;ndez</surname><given-names>C</given-names></name><name><surname>P&#x000e1;ez</surname><given-names>E</given-names></name><name><surname>Vilas</surname><given-names>P</given-names></name><name><surname>Gancedo</surname><given-names>G</given-names></name></person-group><article-title>Effect of disodium phosphonoacetate and iododeoxyuridine on the multiplication of African swine fever virus in vitro</article-title><source>Chemotherapy</source><year>1979</year><volume>25</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1159/000237836</pub-id><pub-id pub-id-type="pmid">378573</pub-id></element-citation></ref><ref id="ref-27"><label>Hakobyan et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakobyan</surname><given-names>A</given-names></name><name><surname>Arabyan</surname><given-names>E</given-names></name><name><surname>Avetisyan</surname><given-names>A</given-names></name><name><surname>Abroyan</surname><given-names>L</given-names></name><name><surname>Hakobyan</surname><given-names>L</given-names></name><name><surname>Zakaryan</surname><given-names>H</given-names></name></person-group><article-title>Apigenin inhibits African swine fever virus infection in vitro</article-title><source>Archives of Virology</source><year>2016</year><volume>161</volume><fpage>3445</fpage><lpage>3453</lpage><pub-id pub-id-type="doi">10.1007/s00705-016-3061-y</pub-id><pub-id pub-id-type="pmid">27638776</pub-id></element-citation></ref><ref id="ref-28"><label>Hakobyan et al. (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakobyan</surname><given-names>A</given-names></name><name><surname>Arabyan</surname><given-names>E</given-names></name><name><surname>Kotsinyan</surname><given-names>A</given-names></name><name><surname>Karalyan</surname><given-names>Z</given-names></name><name><surname>Sahakyan</surname><given-names>H</given-names></name><name><surname>Arakelov</surname><given-names>V</given-names></name><name><surname>Nazaryan</surname><given-names>K</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name><name><surname>Zakaryan</surname><given-names>H</given-names></name></person-group><article-title>Inhibition of African swine fever virus infection by genkwanin</article-title><source>Antiviral Research</source><year>2019</year><volume>167</volume><fpage>78</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">30991087</pub-id></element-citation></ref><ref id="ref-29"><label>Hakobyan et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakobyan</surname><given-names>A</given-names></name><name><surname>Galindo</surname><given-names>I</given-names></name><name><surname>Na&#x000f1;ez</surname><given-names>A</given-names></name><name><surname>Arabyan</surname><given-names>E</given-names></name><name><surname>Karalyan</surname><given-names>Z</given-names></name><name><surname>Chistov</surname><given-names>AA</given-names></name><name><surname>Streshnev</surname><given-names>PP</given-names></name><name><surname>Korshun</surname><given-names>VA</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name><name><surname>Zakaryan</surname><given-names>H</given-names></name></person-group><article-title>Rigid amphipathic fusion inhibitors demonstrate antiviral activity against African swine fever virus</article-title><source>Journal of General Virology</source><year>2018</year><volume>99</volume><fpage>148</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.000991</pub-id><pub-id pub-id-type="pmid">29235978</pub-id></element-citation></ref><ref id="ref-30"><label>Han et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Bo</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Human enterovirus 71 protein interaction network prompts antiviral drug repositioning</article-title><source>Scientific Reports</source><year>2017</year><volume>7</volume><fpage>43143</fpage><pub-id pub-id-type="doi">10.1038/srep43143</pub-id><pub-id pub-id-type="pmid">28220872</pub-id></element-citation></ref><ref id="ref-31"><label>He, Duan &#x00026; Tan (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>S-L</given-names></name></person-group><article-title>Emerging host cell targets for hepatitis C therapy</article-title><source>Drug Discovery Today</source><year>2007</year><volume>12</volume><issue>5&#x02013;6</issue><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">17331885</pub-id></element-citation></ref><ref id="ref-32"><label>Hernaez, Escribano &#x00026; Alonso (2008)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernaez</surname><given-names>B</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>African swine fever virus protein p30 interaction with heterogeneous nuclear ribonucleoprotein K (hnRNP-K) during infection</article-title><source>FEBS Letters</source><year>2008</year><volume>582</volume><issue>23&#x02013;24</issue><fpage>3275</fpage><lpage>3280</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2008.08.031</pub-id><pub-id pub-id-type="pmid">18775702</pub-id></element-citation></ref><ref id="ref-33"><label>Hern&#x000e1;ez et al. (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ez</surname><given-names>B</given-names></name><name><surname>Tarrag&#x000f3;</surname><given-names>T</given-names></name><name><surname>Giralt</surname><given-names>E</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein</article-title><source>Journal of Virology</source><year>2010</year><volume>84</volume><issue>20</issue><fpage>10792</fpage><lpage>10801</lpage><pub-id pub-id-type="doi">10.1128/JVI.01168-10</pub-id><pub-id pub-id-type="pmid">20686048</pub-id></element-citation></ref><ref id="ref-34"><label>Hurtado et al. (2008)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurtado</surname><given-names>C</given-names></name><name><surname>Bustos</surname><given-names>MJ</given-names></name><name><surname>Sabina</surname><given-names>P</given-names></name><name><surname>Nogal</surname><given-names>ML</given-names></name><name><surname>Granja</surname><given-names>AG</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>ME</given-names></name><name><surname>G&#x000f3;nzalez-Porqu&#x000e9;</surname><given-names>P</given-names></name><name><surname>Revilla</surname><given-names>Y</given-names></name><name><surname>Carrascosa</surname><given-names>AL</given-names></name></person-group><article-title>Antiviral activity of lauryl gallate against animal viruses</article-title><source>Antiviral Therapy</source><year>2008</year><volume>13</volume><issue>7</issue><fpage>909</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">19043925</pub-id></element-citation></ref><ref id="ref-35"><label>Keane et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Gershon</surname><given-names>S</given-names></name><name><surname>Wise</surname><given-names>RP</given-names></name><name><surname>Mirabile-Levens</surname><given-names>E</given-names></name><name><surname>Kasznica</surname><given-names>J</given-names></name><name><surname>Schwieterman</surname><given-names>WD</given-names></name><name><surname>Siegel</surname><given-names>JN</given-names></name><name><surname>Braun</surname><given-names>MM</given-names></name></person-group><article-title>Tuberculosis associated with infliximab, a tumor necrosis factor &#x003b1;-neutralizing agent</article-title><source>New England Journal of Medicine</source><year>2001</year><volume>345</volume><issue>15</issue><fpage>1098</fpage><lpage>1104</lpage><pub-id pub-id-type="pmid">11596589</pub-id></element-citation></ref><ref id="ref-36"><label>Keita, Heath &#x00026; Albina (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keita</surname><given-names>D</given-names></name><name><surname>Heath</surname><given-names>L</given-names></name><name><surname>Albina</surname><given-names>E</given-names></name></person-group><article-title>Control of African swine fever virus replication by small interfering RNA targeting the A151R and VP72 genes</article-title><source>Antiviral Therapy</source><year>2010</year><volume>15</volume><issue>5</issue><fpage>727</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.3851/IMP1593</pub-id><pub-id pub-id-type="pmid">20710054</pub-id></element-citation></ref><ref id="ref-37"><label>Luo, Vasudevan &#x00026; Lescar (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>D</given-names></name><name><surname>Vasudevan</surname><given-names>SG</given-names></name><name><surname>Lescar</surname><given-names>J</given-names></name></person-group><article-title>The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development</article-title><source>Antiviral Research</source><year>2015</year><volume>118</volume><fpage>148</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.03.014</pub-id><pub-id pub-id-type="pmid">25842996</pub-id></element-citation></ref><ref id="ref-38"><label>Mak et al. (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>L-Y</given-names></name><name><surname>Seto</surname><given-names>W-K</given-names></name><name><surname>Fung</surname><given-names>J</given-names></name><name><surname>Yuen</surname><given-names>M-F</given-names></name></person-group><article-title>Novel developments of hepatitis B: treatment goals, agents and monitoring tools</article-title><source>Expert Review of Clinical Pharmacology</source><year>2019</year><volume>12</volume><issue>2</issue><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1080/17512433.2019.1567327</pub-id><pub-id pub-id-type="pmid">30621472</pub-id></element-citation></ref><ref id="ref-39"><label>Malogolovkin et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malogolovkin</surname><given-names>A</given-names></name><name><surname>Yelsukova</surname><given-names>A</given-names></name><name><surname>Gallardo</surname><given-names>C</given-names></name><name><surname>Tsybanov</surname><given-names>S</given-names></name><name><surname>Kolbasov</surname><given-names>D</given-names></name></person-group><article-title>Molecular characterization of African swine fever virus isolates originating from outbreaks in the Russian Federation between</article-title><source>Veterinary Microbiology</source><year>2012</year><volume>158</volume><issue>3&#x02013;4</issue><fpage>415</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2012.03.002</pub-id><pub-id pub-id-type="pmid">22445729</pub-id></element-citation></ref><ref id="ref-40"><label>Miskin et al. (1998)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miskin</surname><given-names>JE</given-names></name><name><surname>Abrams</surname><given-names>CC</given-names></name><name><surname>Goatley</surname><given-names>LC</given-names></name><name><surname>Dixon</surname><given-names>LK</given-names></name></person-group><article-title>A viral mechanism for inhibition of the cellular phosphatase calcineurin</article-title><source>Science</source><year>1998</year><volume>281</volume><issue>5376</issue><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1126/science.281.5376.562</pub-id><pub-id pub-id-type="pmid">9677199</pub-id></element-citation></ref><ref id="ref-41"><label>Monto (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monto</surname><given-names>AS</given-names></name></person-group><article-title>Vaccines and antiviral drugs in pandemic preparedness</article-title><source>Emerging Infectious Diseases</source><year>2006</year><volume>12</volume><issue>1</issue><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.3201/eid1201.051068</pub-id><pub-id pub-id-type="pmid">16494718</pub-id></element-citation></ref><ref id="ref-42"><label>Mottola et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mottola</surname><given-names>C</given-names></name><name><surname>Freitas</surname><given-names>FB</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>M</given-names></name><name><surname>Martins</surname><given-names>C</given-names></name><name><surname>Leit&#x000e3;o</surname><given-names>A</given-names></name><name><surname>Ferreira</surname><given-names>F</given-names></name></person-group><article-title>In vitro antiviral activity of fluoroquinolones against African swine fever virus</article-title><source>Veterinary Microbiology</source><year>2013</year><volume>165</volume><issue>1&#x02013;2</issue><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2013.01.018</pub-id><pub-id pub-id-type="pmid">23415476</pub-id></element-citation></ref><ref id="ref-43"><label>Nogal et al. (2001)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogal</surname><given-names>ML</given-names></name><name><surname>De Buitrago</surname><given-names>GG</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>C</given-names></name><name><surname>Cubelos</surname><given-names>B</given-names></name><name><surname>Carrascosa</surname><given-names>AL</given-names></name><name><surname>MaL</surname><given-names>Salas</given-names></name><name><surname>Revilla</surname><given-names>Y</given-names></name></person-group><article-title>African swine fever virus IAP homologue inhibits caspase activation and promotes cell survival in mammalian cells</article-title><source>Journal of Virology</source><year>2001</year><volume>75</volume><issue>6</issue><fpage>2535</fpage><lpage>2543</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.6.2535-2543.2001</pub-id><pub-id pub-id-type="pmid">11222676</pub-id></element-citation></ref><ref id="ref-44"><label>Paez, Garcia &#x00026; Fernandez (1990)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paez</surname><given-names>E</given-names></name><name><surname>Garcia</surname><given-names>F</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name></person-group><article-title>Interferon cures cells lytically and persistently infected with African swine fever virus in vitro</article-title><source>Archives of Virology</source><year>1990</year><volume>112</volume><issue>1&#x02013;2</issue><fpage>115</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1007/bf01348989</pub-id><pub-id pub-id-type="pmid">1695091</pub-id></element-citation></ref><ref id="ref-45"><label>Pruitt, Tatusova &#x00026; Maglott (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruitt</surname><given-names>KD</given-names></name><name><surname>Tatusova</surname><given-names>T</given-names></name><name><surname>Maglott</surname><given-names>DR</given-names></name></person-group><article-title>NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins</article-title><source>Nucleic Acids Research</source><year>2005</year><volume>33</volume><issue>Database issue</issue><fpage>D501</fpage><lpage>D504</lpage><pub-id pub-id-type="doi">10.1093/nar/gki025</pub-id><pub-id pub-id-type="pmid">15608248</pub-id></element-citation></ref><ref id="ref-46"><label>Ramiro-Ib&#x000e1;&#x000f1;ez et al. (1996)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramiro-Ib&#x000e1;&#x000f1;ez</surname><given-names>F</given-names></name><name><surname>Ortega</surname><given-names>A</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>Apoptosis: a mechanism of cell killing and lymphoid organ impairment during acute African swine fever virus infection</article-title><source>Journal of General Virology</source><year>1996</year><volume>77</volume><issue>9</issue><fpage>2209</fpage><lpage>2219</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-77-9-2209</pub-id><pub-id pub-id-type="pmid">8811021</pub-id></element-citation></ref><ref id="ref-47"><label>Revilla, Perez-Nunez &#x00026; Richt (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revilla</surname><given-names>Y</given-names></name><name><surname>Perez-Nunez</surname><given-names>D</given-names></name><name><surname>Richt</surname><given-names>JA</given-names></name></person-group><article-title>African swine fever virus biology and vaccine approaches</article-title><source>Advances in Virus Research</source><year>2018</year><volume>100</volume><fpage>41</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/bs.aivir.2017.10.002</pub-id><pub-id pub-id-type="pmid">29551143</pub-id></element-citation></ref><ref id="ref-48"><label>Rivera et al. (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>J</given-names></name><name><surname>Abrams</surname><given-names>C</given-names></name><name><surname>Hern&#x000e1;ez</surname><given-names>B</given-names></name><name><surname>Alc&#x000e1;zar</surname><given-names>A</given-names></name><name><surname>Escribano</surname><given-names>JM</given-names></name><name><surname>Dixon</surname><given-names>L</given-names></name><name><surname>Alonso</surname><given-names>C</given-names></name></person-group><article-title>The MyD116 African swine fever virus homologue interacts with the catalytic subunit of protein phosphatase 1 and activates its phosphatase activity</article-title><source>Journal of Virology</source><year>2007</year><volume>81</volume><issue>6</issue><fpage>2923</fpage><lpage>2929</lpage><pub-id pub-id-type="doi">10.1128/JVI.02077-06</pub-id><pub-id pub-id-type="pmid">17215279</pub-id></element-citation></ref><ref id="ref-49"><label>Rodr&#x000ed;guez &#x00026; Salas (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>JM</given-names></name><name><surname>Salas</surname><given-names>ML</given-names></name></person-group><article-title>African swine fever virus transcription</article-title><source>Virus Research</source><year>2013</year><volume>173</volume><issue>1</issue><fpage>15</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2012.09.014</pub-id><pub-id pub-id-type="pmid">23041356</pub-id></element-citation></ref><ref id="ref-50"><label>Rozenblatt-Rosen et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Deo</surname><given-names>RC</given-names></name><name><surname>Padi</surname><given-names>M</given-names></name><name><surname>Adelmant</surname><given-names>G</given-names></name><name><surname>Calderwood</surname><given-names>MA</given-names></name><name><surname>Rolland</surname><given-names>T</given-names></name><name><surname>Grace</surname><given-names>M</given-names></name><name><surname>Dricot</surname><given-names>A</given-names></name><name><surname>Askenazi</surname><given-names>M</given-names></name><name><surname>Tavares</surname><given-names>M</given-names></name><name><surname>Pevzner</surname><given-names>SJ</given-names></name><name><surname>Abderazzaq</surname><given-names>F</given-names></name><name><surname>Byrdsong</surname><given-names>D</given-names></name><name><surname>Carvunis</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>AA</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Correll</surname><given-names>M</given-names></name><name><surname>Duarte</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>Feltkamp</surname><given-names>MC</given-names></name><name><surname>Ficarro</surname><given-names>SB</given-names></name><name><surname>Franchi</surname><given-names>R</given-names></name><name><surname>Garg</surname><given-names>BK</given-names></name><name><surname>Gulbahce</surname><given-names>N</given-names></name><name><surname>Hao</surname><given-names>T</given-names></name><name><surname>Holthaus</surname><given-names>AM</given-names></name><name><surname>James</surname><given-names>R</given-names></name><name><surname>Korkhin</surname><given-names>A</given-names></name><name><surname>Litovchick</surname><given-names>L</given-names></name><name><surname>Mar</surname><given-names>JC</given-names></name><name><surname>Pak</surname><given-names>TR</given-names></name><name><surname>Rabello</surname><given-names>S</given-names></name><name><surname>Rubio</surname><given-names>R</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Spangle</surname><given-names>JM</given-names></name><name><surname>Tasan</surname><given-names>M</given-names></name><name><surname>Wanamaker</surname><given-names>S</given-names></name><name><surname>Webber</surname><given-names>JT</given-names></name><name><surname>Roecklein-Canfield</surname><given-names>J</given-names></name><name><surname>Johannsen</surname><given-names>E</given-names></name><name><surname>Barab&#x000e1;si</surname><given-names>AL</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Kieff</surname><given-names>E</given-names></name><name><surname>Cusick</surname><given-names>ME</given-names></name><name><surname>Hill</surname><given-names>DE</given-names></name><name><surname>M&#x000fc;nger</surname><given-names>K</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Quackenbush</surname><given-names>J</given-names></name><name><surname>Roth</surname><given-names>FP</given-names></name><name><surname>DeCaprio</surname><given-names>JA</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name></person-group><article-title>Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins</article-title><source>Nature</source><year>2012</year><volume>487</volume><issue>7408</issue><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/nature11288</pub-id><pub-id pub-id-type="pmid">22810586</pub-id></element-citation></ref><ref id="ref-51"><label>Sessions et al. (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sessions</surname><given-names>OM</given-names></name><name><surname>Barrows</surname><given-names>NJ</given-names></name><name><surname>Souza-Neto</surname><given-names>JA</given-names></name><name><surname>Robinson</surname><given-names>TJ</given-names></name><name><surname>Hershey</surname><given-names>CL</given-names></name><name><surname>Rodgers</surname><given-names>MA</given-names></name><name><surname>Ramirez</surname><given-names>JL</given-names></name><name><surname>Dimopoulos</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>PL</given-names></name><name><surname>Pearson</surname><given-names>J</given-names></name><name><surname>Garcia-Blanco</surname><given-names>MA</given-names></name></person-group><article-title>Discovery of insect and human dengue virus host factors</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>1047</fpage><lpage>1050</lpage><pub-id pub-id-type="doi">10.1038/nature07967</pub-id><pub-id pub-id-type="pmid">19396146</pub-id></element-citation></ref><ref id="ref-52"><label>Su et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Demchak</surname><given-names>B</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name></person-group><article-title>Biological network exploration with Cytoscape 3</article-title><source>Current Protocols in Bioinformatics</source><year>2014</year><volume>47</volume><issue>1</issue><fpage>8.13.1</fpage><lpage>18.13.24</lpage><pub-id pub-id-type="doi">10.1002/0471250953.bi0813s47</pub-id><pub-id pub-id-type="pmid">25199793</pub-id></element-citation></ref><ref id="ref-53"><label>Szklarczyk et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Cook</surname><given-names>H</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Wyder</surname><given-names>S</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>A</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>Von Mering</surname><given-names>C</given-names></name></person-group><article-title>The STRING database in 2017: quality-controlled protein&#x02013;protein association networks, made broadly accessible</article-title><source>Nucleic Acids Research</source><year>2016</year><volume>45</volume><issue>D1</issue><fpage>D362</fpage><lpage>D368</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw937</pub-id><pub-id pub-id-type="pmid">27924014</pub-id></element-citation></ref><ref id="ref-54"><label>S&#x000e1;nchez, P&#x000e9;rez-N&#x000fa;&#x000f1;ez &#x00026; Revilla (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez</surname><given-names>EG</given-names></name><name><surname>P&#x000e9;rez-N&#x000fa;&#x000f1;ez</surname><given-names>D</given-names></name><name><surname>Revilla</surname><given-names>Y</given-names></name></person-group><article-title>Development of vaccines against African swine fever virus</article-title><source>Virus Research</source><year>2019</year><volume>265</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2019.03.022</pub-id><pub-id pub-id-type="pmid">30922809</pub-id></element-citation></ref><ref id="ref-55"><label>S&#x000e1;nchez-Cord&#x000f3;n et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Cord&#x000f3;n</surname><given-names>P</given-names></name><name><surname>Montoya</surname><given-names>M</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name><name><surname>Dixon</surname><given-names>LK</given-names></name></person-group><article-title>African swine fever: a re-emerging viral disease threatening the global pig industry</article-title><source>Veterinary Journal</source><year>2018</year><volume>233</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.tvjl.2017.12.025</pub-id></element-citation></ref><ref id="ref-56"><label>Tan et al. (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>S-L</given-names></name><name><surname>Ganji</surname><given-names>G</given-names></name><name><surname>Paeper</surname><given-names>B</given-names></name><name><surname>Proll</surname><given-names>S</given-names></name><name><surname>Katze</surname><given-names>MG</given-names></name></person-group><article-title>Systems biology and the host response to viral infection</article-title><source>Nature Biotechnology</source><year>2007</year><volume>25</volume><fpage>1383</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1038/nbt1207-1383</pub-id></element-citation></ref><ref id="ref-57"><label>Tavassoli (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavassoli</surname><given-names>A</given-names></name></person-group><article-title>Targeting the protein&#x02013;protein interactions of the HIV lifecycle</article-title><source>Chemical Society Reviews</source><year>2011</year><volume>40</volume><issue>3</issue><fpage>1337</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1039/c0cs00092b</pub-id><pub-id pub-id-type="pmid">21152581</pub-id></element-citation></ref><ref id="ref-58"><label>Uetz et al. (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uetz</surname><given-names>P</given-names></name><name><surname>Dong</surname><given-names>Y-A</given-names></name><name><surname>Zeretzke</surname><given-names>C</given-names></name><name><surname>Atzler</surname><given-names>C</given-names></name><name><surname>Baiker</surname><given-names>A</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>Rajagopala</surname><given-names>SV</given-names></name><name><surname>Roupelieva</surname><given-names>M</given-names></name><name><surname>Rose</surname><given-names>D</given-names></name><name><surname>Fossum</surname><given-names>E</given-names></name><name><surname>Haas</surname><given-names>J</given-names></name></person-group><article-title>Herpesviral protein networks and their interaction with the human proteome</article-title><source>Science</source><year>2006</year><volume>311</volume><issue>5758</issue><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1126/science.1116804</pub-id><pub-id pub-id-type="pmid">16339411</pub-id></element-citation></ref><ref id="ref-59"><label>Wang et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>HJ</given-names></name></person-group><article-title>Prevention, control and vaccine development of African swine fever: challenges and countermeasures</article-title><source>Sheng Wu Gong Cheng Xue Bao</source><year>2018</year><volume>34</volume><issue>12</issue><fpage>1931</fpage><lpage>1942</lpage><pub-id pub-id-type="pmid">30584704</pub-id></element-citation></ref><ref id="ref-60"><label>Wishart et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>DS</given-names></name><name><surname>Feunang</surname><given-names>YD</given-names></name><name><surname>Guo</surname><given-names>AC</given-names></name><name><surname>Lo</surname><given-names>EJ</given-names></name><name><surname>Marcu</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>JR</given-names></name><name><surname>Sajed</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Sayeeda</surname><given-names>Z</given-names></name><name><surname>Assempour</surname><given-names>N</given-names></name><name><surname>Iynkkaran</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Maciejewski</surname><given-names>A</given-names></name><name><surname>Gale</surname><given-names>N</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>L</given-names></name><name><surname>Cummings</surname><given-names>R</given-names></name><name><surname>Le</surname><given-names>D</given-names></name><name><surname>Pon</surname><given-names>A</given-names></name><name><surname>Knox</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name></person-group><article-title>DrugBank 5.0: a major update to the DrugBank database for</article-title><source>Nucleic Acids Research</source><year>2018</year><volume>46</volume><issue>D1</issue><fpage>D1074</fpage><lpage>D1082</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id><pub-id pub-id-type="pmid">29126136</pub-id></element-citation></ref><ref id="ref-61"><label>Yang et al. (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Lian</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><article-title>Understanding human-virus protein&#x02013;protein interactions using a human protein complex-based analysis framework</article-title><source>mSystems</source><year>2019</year><volume>4</volume><fpage>e00303-18</fpage><pub-id pub-id-type="doi">10.1128/mSystems.00303-18</pub-id><pub-id pub-id-type="pmid">30984872</pub-id></element-citation></ref><ref id="ref-62"><label>Yu et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>L-G</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Q-Y</given-names></name></person-group><article-title>ClusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS: A Journal of Integrative Biology</source><year>2012</year><volume>16</volume><issue>5</issue><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="ref-63"><label>Zakaryan &#x00026; Revilla (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakaryan</surname><given-names>H</given-names></name><name><surname>Revilla</surname><given-names>Y</given-names></name></person-group><article-title>African swine fever virus: current state and future perspectives in vaccine and antiviral research</article-title><source>Veterinary Microbiology</source><year>2016</year><volume>185</volume><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2016.01.016</pub-id><pub-id pub-id-type="pmid">26931386</pub-id></element-citation></ref><ref id="ref-64"><label>Zhou et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Miao</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>K</given-names></name><name><surname>Qiu</surname><given-names>H-J</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name></person-group><article-title>Emergence of African swine fever in China, 2018</article-title><source>Transboundary and Emerging Diseases</source><year>2018</year><volume>65</volume><issue>6</issue><fpage>1482</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.1111/tbed.12989</pub-id><pub-id pub-id-type="pmid">30102848</pub-id></element-citation></ref></ref-list></back></article>